Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2005
12/15/2005CA2567080A1 Ice inhibitors for the treatment of autoinflammatory diseases
12/15/2005CA2560472A1 Method for improved breast milk feeding to reduce the risk of allergy
12/14/2005EP1605040A1 Monocyte-origin multipotent cell momc
12/14/2005EP1604984A1 Water-soluble phenylpyridazine derivative and medicine containing the same
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604981A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/14/2005EP1604681A1 Use of botulinum toxin in the treatment of joint pain
12/14/2005EP1604680A1 Use of botulinum toxin in the treatment of neuralgia pain
12/14/2005EP1604679A1 Use of botulinum toxin in the treatment of visceral pain
12/14/2005EP1604678A1 Use of botulinum toxin in the treatment of post-operative pain
12/14/2005EP1604650A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
12/14/2005EP1603921A1 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
12/14/2005EP1603907A1 Substituted pyrido(1,2-a)pyrimidines and their use as nos inhibitors
12/14/2005EP1603905A1 Vanilloid receptor ligands and their use in treatments
12/14/2005EP1603901A1 Tetrahydropyran compounds as tachykinin antagonists
12/14/2005EP1603899A1 Heterocyclic urea derivatives for the treatment of pain
12/14/2005EP1603897A1 Pyrazole compounds useful in the treatment of inflammation
12/14/2005EP1603883A2 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/14/2005EP1603872A1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt
12/14/2005EP1603871A1 S-[2-[(i-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate crystalline salt
12/14/2005EP1603870A1 S- 2- (1-iminoethyl)amino ethyl -2-methyl-l-c ysteine salicylate monohydrate crystalline salt
12/14/2005EP1603869A1 S- 2- (1-iminoethyl)amino ethyl -2-methyl-l-c ysteine maleate form ii crystalline salt
12/14/2005EP1496902B1 Medicament containing steroids and a novel anticholinergic drug
12/14/2005EP1492550B1 Willow extract
12/14/2005EP1438290B1 Cyclohept b!indole derivatives as spla2 inhibitors
12/14/2005EP1284771B1 Aerosol container for formulations of salmeterol xinafoate
12/14/2005EP1280904B1 Pain signaling molecules
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1261309B1 Device for calculating elixir doses appropriate for a patient's weight
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005EP1178821B1 Use of anti-hbp antibodies in the inhibition of bradykinin release
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation
12/14/2005CN1708507A 9a-azalides with anti-inflammatory activity
12/14/2005CN1708489A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708304A Use of piperazine sulfonic acid derivatives as CCR1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders
12/14/2005CN1706833A Formyl peptide-like acceptor-1 regulator and its prepn and use
12/14/2005CN1706378A Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
12/14/2005CN1231474C Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/14/2005CN1231251C Colitis therapeutic traditional Chinese medicine
12/14/2005CN1231246C Medicinal liquid for activating meridians
12/14/2005CN1231243C Medicinal recipe for treating rheumatalgia
12/14/2005CN1231238C Chinese medicine for inflammation and swelling
12/14/2005CN1231235C Bolus for eliminating arthralgia and activating energy flow in channels and collaterals and its preparing method
12/14/2005CN1231228C Drug moxibustion product with effect of promoting flow of qi and blood circulation and assuaging pain
12/14/2005CN1231209C Ursolic acid poly lactic acid nano particle freeze dried powder injection and its preparation method
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974831 sPLA2 inhibitors
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974818 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
12/13/2005US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974809 Inhibitors of interleukin 1-β converting enzyme
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/13/2005US6974791 These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium.
12/13/2005CA2271054C Substituted phenols and thiophenols useful as antioxidant agents
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/13/2005CA2090634C Novel cyclosporins
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116067A2 Msh-agonist tripeptide conjugates
12/08/2005WO2005116015A1 Chromanol derivatives, method for the production thereof, and use thereof as an anti-inflammatory drug
12/08/2005WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/08/2005WO2005115468A1 Novel drug discovery target and medicine acting on the same
12/08/2005WO2005115443A1 Chronic articular inflammation-modulating composition based on collagen-polyvinylpyrrolidone
12/08/2005WO2005115344A1 Oral delivery system
12/08/2005WO2004099126A8 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005WO2004058042A3 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005WO2002057256A9 Piperazinylcarbonylquinolines and -isoquinolines
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272806 Injectable formulations of taxanes for cad treatment
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272756 Pyridopyrrolizine and pyridoindolizine derivatives
12/08/2005US20050272750 Novel compound
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005US20050272732 5-ethyl-imidazo (5,1-F) (1,2,4,) triazin-4 (3h)-ones as phosphodiesterase inhibitors
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
12/08/2005US20050272701 Pharmaceutical composition
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
1 ... 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 ... 1272